Condition
Boils
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03275870Phase 1Completed
Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
NCT00746109Phase 4Completed
Study of Wound Packing After Superficial Skin Abscess Drainage
NCT01032499Phase 3Unknown
Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir
Showing all 3 trials